ATE41144T1 - Verfahren zur racemisierung. - Google Patents

Verfahren zur racemisierung.

Info

Publication number
ATE41144T1
ATE41144T1 AT86301417T AT86301417T ATE41144T1 AT E41144 T1 ATE41144 T1 AT E41144T1 AT 86301417 T AT86301417 T AT 86301417T AT 86301417 T AT86301417 T AT 86301417T AT E41144 T1 ATE41144 T1 AT E41144T1
Authority
AT
Austria
Prior art keywords
racemisation
procedure
alkali metal
phenylpropylamine
epimerization
Prior art date
Application number
AT86301417T
Other languages
English (en)
Inventor
Jerry Wayne Misner
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE41144T1 publication Critical patent/ATE41144T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B55/00Racemisation; Complete or partial inversion
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AT86301417T 1985-02-27 1986-02-27 Verfahren zur racemisierung. ATE41144T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/706,373 US4777291A (en) 1985-02-27 1985-02-27 Racemization process
EP86301417A EP0193405B1 (de) 1985-02-27 1986-02-27 Verfahren zur Racemisierung

Publications (1)

Publication Number Publication Date
ATE41144T1 true ATE41144T1 (de) 1989-03-15

Family

ID=24837278

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86301417T ATE41144T1 (de) 1985-02-27 1986-02-27 Verfahren zur racemisierung.

Country Status (9)

Country Link
US (1) US4777291A (de)
EP (1) EP0193405B1 (de)
JP (1) JPS61210059A (de)
KR (1) KR870002180B1 (de)
AT (1) ATE41144T1 (de)
CA (1) CA1269997A (de)
DE (1) DE3662262D1 (de)
HU (1) HU196586B (de)
IL (1) IL77978A0 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8419683D0 (en) * 1984-08-02 1984-09-05 Erba Farmitalia 3-substituted derivatives of 1-amino-2-hydroxy-propane
US5320825A (en) * 1991-05-01 1994-06-14 Trustees Of The University Of Pennsylvania Serotonin reuptake inhibitors for S.P.E.C.T. imaging
WO2000058262A1 (en) * 1999-03-29 2000-10-05 Eli Lilly And Company Stereospecific method for preparing tomoxetine and intermediates thereof
GB0229583D0 (en) * 2002-12-19 2003-01-22 Cipla Ltd A process for preparing duloxetine and intermediates for use therein
US20060100290A1 (en) * 2003-07-28 2006-05-11 Dunaway Leslie J Treatment of allergic rhinitis and asthma
CA2552064A1 (en) * 2003-12-31 2005-07-21 Actavis Group Hf Atomoxetine formulations
ES2313387T3 (es) * 2004-06-28 2009-03-01 Teva Pharmaceutical Fine Chemicals S.R.L. Impureza de atomoxetina aislada, procedimiento para la preparacion de impurezas de atomoxetina y su utilizacion como patrones de referencia.
US7439399B2 (en) * 2004-06-28 2008-10-21 Teva Pharmaceutical Fine Chemicals Processes for the preparation of atomoxetine hydrochloride
EP1768949A2 (de) * 2004-07-22 2007-04-04 Teva Pharmaceutical Fine Chemicals S.R.L. Polymorphe von atomoxetien-hydrochlorid
WO2006037055A1 (en) * 2004-09-27 2006-04-06 Dr. Reddy's Laboratories Ltd. Synthesis of atomoxetine hydrochloride
US7569729B2 (en) * 2005-04-05 2009-08-04 Teva Pharmaceutical Fine Chemicals S.R.L. Stable atomoxetine hydrochloride, a process for the preparation thereof, and an analytical control of its stability
US7485754B2 (en) * 2005-07-08 2009-02-03 Apotex Pharmachem Inc. Efficient method for preparing 3-aryloxy-3-arylpropylamines and their optical stereoisomers
US20080146675A1 (en) * 2006-04-05 2008-06-19 Eugenio Castelli Stable Atomoxetine Hydrochloride, a process for the preparation thereof, and an analytical control of its stability
EP2364977A1 (de) 2010-01-26 2011-09-14 Reuter Chemische Apparatebau KG Verfahren zur Enantiomerenanreicherung von 3-Methyl-1-(2-Piperidinphenyl)-1-Butylamin
CN113336654B (zh) * 2020-02-18 2022-12-09 上海医药工业研究院 一种n-甲基-3-(2-甲基苯氧基)苯丙胺的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3168566A (en) * 1961-09-01 1965-02-02 Nopco Chem Co Process for racemizing alpha-phenyl and alpha-naphthyl ethylamines
FR2242349B1 (de) * 1973-08-31 1977-03-25 Sumitomo Chemical Co
US4158016A (en) * 1973-08-31 1979-06-12 Sumitomo Chemical Company, Limited Method for racemization of optically active amines
DE2348801A1 (de) * 1973-09-28 1975-04-10 Dynamit Nobel Ag Verfahren zur racemisierung von optisch aktivem 1-phenylaethylamin
US4314081A (en) * 1974-01-10 1982-02-02 Eli Lilly And Company Arloxyphenylpropylamines
GR75395B (de) * 1980-11-14 1984-07-13 Lilly Co Eli

Also Published As

Publication number Publication date
DE3662262D1 (en) 1989-04-13
US4777291A (en) 1988-10-11
EP0193405A1 (de) 1986-09-03
JPS61210059A (ja) 1986-09-18
IL77978A0 (en) 1986-08-31
EP0193405B1 (de) 1989-03-08
HUT42055A (en) 1987-06-29
KR860006433A (ko) 1986-09-11
CA1269997A (en) 1990-06-05
KR870002180B1 (ko) 1987-12-28
HU196586B (en) 1988-12-28

Similar Documents

Publication Publication Date Title
ATE41144T1 (de) Verfahren zur racemisierung.
HUP0000777A2 (hu) Ritalinsav só rezolválása
GB1261469A (en) An optical isomer of chrysanthemic acid and processes for preparing it
DE3851022D1 (de) Verfahren zur Herstellung von verzweigten Fructo-Oligosacchariden.
GB1495163A (en) Resolution of racemic pantolactone
ES8800215A1 (es) Un procedimiento enantioselectivo para la preparacion de intermedios para los antibioticos de 1-b-metil-carbapenem
DK588286D0 (da) Fremgangsmaade til fremstilling af 5-(2,5-dimethylphenoxy)-2,2-dimethylpentansyre
EP0188235A3 (en) Production of optically pure organoboranes
HUT37444A (en) Process for preparing bestatin derivatives
CA1257599A (en) TRANS-3-[(4-METHOXYPHENOXY)-METHYL]-1-METHYL- 4-PHENYLPIPERIDINE
KR840006626A (ko) 케토화합물의 제조방법
KR890012988A (ko) 3,3-디아릴아크릴 산 아미드의 제법
GB1490123A (en) 3-alkanoyloxyquinuclidines
ES8105970A1 (es) Procedimiento para preparar acidos metil aminoalcanoicos fluorados.
EP0170148A3 (de) Verfahren zur Herstellung von alpha-L-Aspartyl-L-phenylalanin-Alkylestern
AR246262A1 (es) Procedimiento para obtener derivados racemicos y opticamente activos de los acidos 9- y 11-nitroapovincamicos.
ES8200092A1 (es) Procedimiento para la sintesis de esteres de la n-(4'hidro- xifenil) acetamida con acidos 5-benzoil-1-metilpirrol-2-ace-tico
EP0169725A3 (en) New method of treatment using prostaglandin analogues
ES502668A0 (es) Procedimiento para preparar una solucion hidrocarbonada de un compuesto de alquilsodio
DK159432C (da) Fremgangsmaade til fremstilling af 4-amino-5-dialkoxymethylpyrimidinderivater
IE800588L (en) Piperidinothiazolidines
DE2963107D1 (en) Process for preparing amino acids and esters
DE3772703D1 (de) Verfahren zur herstellung von penemen.
JPS56135447A (en) Optical resolving method of alpha-phenyl-beta- p-tolyl ethylamine
JPS545957A (en) Racemization of optical active alpha-naphthylethylamine

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee